Latest Regulatory Progress News

Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.

BMC Minerals has cleared a major regulatory milestone for its ABM Mine in Yukon and reported thick, high-grade massive sulfide intercepts at its Krakatoa Zone, supporting resource expansion and a 2027 Final Investment Decision target.

Global Lithium Resources has sharpened its focus on the Manna Lithium Project following the spin-out of its Marble Bar gold assets. The company secured crucial permitting submissions and a significant funding and offtake deal, underpinning its path to a Final Investment Decision in 2026.

Kinetiko Energy has unveiled a staged gas production strategy in South Africa, aiming for initial compressed natural gas revenues by Q2/Q3 2027. The company’s new Rolling Cluster Development Strategy promises a risk-managed, capital-efficient pathway from early CNG production to full-field LNG.

EBR Systems secures Priority Review from Australia's TGA for its wireless cardiac pacing system, fast-tracking regulatory approval and expanding access for heart failure patients. This follows strong US commercial momentum after FDA approval.

Medallion Metals is advancing plans to refurbish the Cosmic Boy Concentrator at Forrestania, aiming to accelerate gold production and generate near-term cashflow before its Ravensthorpe ore processing begins.

Brazilian Critical Minerals (ASX: BCM) has reinforced the scale and quality of its Ema rare earth project with strong drilling results and steady progress on permitting and feasibility studies, positioning it well amid tightening global supply.

Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.

Jindalee Lithium is set to list its McDermitt lithium project on NASDAQ through a US SPAC deal valuing the assets at US$571 million, while securing key US federal approvals and advancing magnesium by-product potential.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Recce Pharmaceuticals has cleared a critical regulatory hurdle in Indonesia with a successful inspection of its Phase 3 clinical trial site for diabetic foot infections, paving the way for potential approval in 2026 amid a large and growing market.

Vintage Energy and Vault Energy have agreed to negotiate a gas sales deal for Cullen-1 gas, aiming to fuel modular data centres onsite if flow tests confirm commercial viability. Vintage plans to fund testing via farm-out once permit tenure is secured.